US Patent Issued to The Research Institute at Nationwide Children's Hospital on Feb. 4 for "Factor XIII immunoassay" (Ohio Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,216,130, issued on Feb. 4, was assigned to The Research Institute at Nationwide Children's Hospital (Columbus, Ohio).

"Factor XIII immunoassay" was invented by Bryce A Kerlin (Galena, Ohio), Michael A. Durda (Columbus, Ohio), Amanda P. Waller (Whitehall, Ohio) and Katelyn J. Wolfgang (Hilliard, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of detecting factor XIII activity in a biological sample is described. The method includes the steps of immobilizing or having obtained a capture antibody on a solid support, wherein the capture antibody comprises an antibody or antibody fragment that specifically binds to fibrinogen; incubating the biol...